A randomized, double blind, parallel group, active-controlled, multi-center, 14 week study to evaluate the effectiveness of a valsartan versus an amlodipine treatment stratgey in achieving blood pressure control in patients with stage 1 or stage 2 hypertension or uncontrolled on present monotherapy

Trial Profile

A randomized, double blind, parallel group, active-controlled, multi-center, 14 week study to evaluate the effectiveness of a valsartan versus an amlodipine treatment stratgey in achieving blood pressure control in patients with stage 1 or stage 2 hypertension or uncontrolled on present monotherapy

Completed
Phase of Trial: Phase IV

Latest Information Update: 10 Mar 2015

At a glance

  • Drugs Valsartan (Primary) ; Amlodipine
  • Indications Hypertension
  • Focus Therapeutic Use
  • Sponsors Novartis
  • Most Recent Events

    • 10 Mar 2015 As EudraCT record, trial is recruiting in Spain and UK and completed in remaining countries; status retained as per NCT.
    • 27 May 2011 Actual initiation date (22 Feb 2006) as reported by EudraCT.
    • 27 May 2011 Actual end date (19 Jan 2007) added as reported by EudraCT (Denmark, Germany).
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top